本帖最后由 成长的烦恼 于 2012-6-27 20:19 编辑
7 O: W0 K1 ^: X# K" }9 u0 b2 S% O( ]( R
clinicaltrials上的三期临床链接: H3 C9 ?! N" X- t% [
- L% B! f6 }8 [
http://clinicaltrials.gov/ct2/sh ... mp;show_locs=Y#locn
0 G) j0 y' S1 h2 w
& Z1 Z- t* Z( ~# b- x中国参加临床实验的城市$ I' a$ y. r1 X2 w
9 F* @. \! j4 [) K) H0 ^
China, Guangdong
9 _& |# E* ?. U& {
! d- v+ s O2 V7 f" [' r* `Guangzhou, Guangdong, China, 510515
5 B, F# G/ g# V g7 I" f2 a
! w7 t4 Y5 q8 u% K8 P1 bGuangzhou, Guangdong, China, 510060
. l3 j7 m! Z2 j7 D' @China, Jiangsu 7 L% k! G" G" b0 L/ c% Y6 D& u
& n6 w7 N$ @, ^2 V, xNanjing, Jiangsu, China, 210009 . I9 U0 @" u5 H1 q9 [
# Q& l3 g( V7 K/ E8 gNanjing, Jiangsu, China, 210002
$ a+ r r( B3 ~! SChina, Shandong
& Y" X) V+ X, J! }# f
6 j1 ~% v% d" @8 Z- M1 \# RQingdao, Shandong, China, 266003 2 @9 [2 q1 }5 e- k
China # H3 I3 F6 y0 ]& A, m
3 }6 T; }: F2 I$ I
Beijing, China, 100021
' ?, r4 j# r+ k \3 z ) l2 Z9 b, H( j' b5 Y1 K
Beijing, China, 100071 2 j; g3 K i5 V, k, \
/ U) V( O* K/ W0 R. G2 V& g/ ^
Changchun, China, 130021 + Q& ^% \# L1 T: e! H( X- t$ G
" p$ p* w6 j1 S1 w% k# kChongqing, China, 400042 ! m: y9 M; S2 e8 v; J
H7 W: O# g$ E0 h
Chongqing, China, 400038 ! w) x F7 \# i9 |: S
) Q' w# \- I1 n& X
Fuzhou, China, 350014
- F* F. t2 s$ H2 D: ]' \6 L 2 V: I4 T4 i0 X' \% h
Fuzhou, China, 350025
' v, W, t1 e6 }6 @ 1 Y# z# R4 Q! U) ~7 e+ Z
Ha'erbin, China, 150040
- L8 ?' ^* C/ _1 X3 R7 A 5 s/ A9 J8 [& ?
Hanghzou, China, 310009 # U+ T3 R9 f5 t" W
- \1 C u, E' f$ A$ _. ^2 CShanghai, China, 200001
; _3 A$ @" p8 w% ^
# u( ^/ H- q( A1 yShanghai, China, 200030 : E3 v1 k4 r+ D/ f. k7 r
' j5 {4 {" _2 W% ]) wTianjin, China ! Y* i1 n" L5 |$ K9 N
1 a: o: N) n1 o& S+ N' [/ {' F
该实验已停止招募,重新开的临床请见临床专用贴。 |